Betterise is a French company based in Biarritz.
We support caregivers in the remote therapy management of their patients with our reliable, secure and certified software.
Our services have already supported more than 500,000 people since 2013 and we’re committed to the further development of our services.
Creation of Betterise Query Language: a proprietary indexing language that translates the complexity and specificity all patients and their environment into data that can be used by a digital therapeutic process.
February 2014: First version of our digital therapy support platform. Algorithms, administration interfaces – everything is ready to create services for our patients.
Creation of the content base.
17 health topics, 2 million words.
Launch of the Primary Prevention service, Betterise.me
With prestigious partners.
Moi, Bientôt Maman is a mobile application to support you during your pregnancy. It’s among the top 3 most downloaded health applications and the no. 1 downloaded pregnancy application.
Over 100,000 users of our services.
Research partnership with Bordeaux University Hospital, Department of Coronary and Vascular Diseases, for the implementation of Therapeutic Support & Remote Monitoring services for Cardiology.
Support service for Type 1 and Type 2 diabetes patients, available for iOS and Android. Agreement with a laboratory for worldwide distribution.
Complete rewriting of the platform and all its components. Enhanced security, more power: BQL now supports more than 3,000 criteria per patient.
Therapeutic support & remote monitoring service for Cardiology.
Start of work on a Patient-Reported Outcomes service for oncology, in collaboration with UNICANCER.
Our services are available in 14 languages, for example in English, Traditional Chinese, Norwegian and Russian.
Over 300,000 users of our services.
Implementation of a comprehensive quality system in conformity with the requirements of ISO 13485:2016, ISO 14971, ISO 62304 and ISO 62366.
Construction of a General Security Policy for Health Information System (PGSSI-S) in conformity with the requirements of the ISO 27001 standard.
Launch of Theraflow, a new-generation remote monitoring and clinical decision support platfor
Our quality management system is ISO 13 485-certified by the French medical devices notified body, GMED.
Declaration to ANSM of our first two Class I Medical Devices, in oncology and cardiology
Added video functionality to allow patient management during containment.
Our products Oncolaxy and Cardiolaxy, medical software for monitoring and clinical decision support in Oncology and Cardiology, have obtained CE marking, Class IIa according to the Medical Devices Directive 93/42 EEC.
More than 500,000 people have used one of our services for their health since 2013.
Simply send us an e-mail and our team will contact you as soon as possible:
We respect patients, caregivers and the applicable regulations.
It may be the smallest of things, but above all it’s what changes everything.
Our products are declared to the ANSM as genuine Medical Devices and carry the CE mark.
We’re certified by GMED as meeting the requirements of the international standard ISO 13485.
We’re aligned with the requirements of PGSSI-S / ISO 27001: the safety of patients and the security of their data is ensured.
We comply with the GDPR requirements on data processing and the provision of good information to our users.